Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name ZN-A-1041
Trade Name
Synonyms ZN-A 1041|ZN-A1041
Drug Descriptions

ZN-A-1041 inhibits ERBB2 (HER2)-mediated downstream signaling, potentially resulting in tumor cell death (NCI Drug Dictionary).

DrugClasses HER2 Inhibitor 38
CAS Registry Number NA
NCIT ID C178299


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Ado-trastuzumab emtansine + ZN-A-1041 Ado-trastuzumab emtansine ZN-A-1041 0 1
Pertuzumab + Trastuzumab + ZN-A-1041 Pertuzumab Trastuzumab ZN-A-1041 0 1
Pertuzumab/trastuzumab/hyaluronidase-zzxf + ZN-A-1041 Pertuzumab/trastuzumab/hyaluronidase-zzxf ZN-A-1041 0 1
Trastuzumab deruxtecan + ZN-A-1041 Trastuzumab deruxtecan ZN-A-1041 0 1
ZN-A-1041 ZN-A-1041 0 1

Additional content available in CKB BOOST